Beta Blocker Overdose Antidote Management
High-dose insulin is the recommended first-line antidote for beta blocker overdose, followed by glucagon and vasopressors for refractory cases. 1
First-Line Therapies
High-Dose Insulin Therapy
- Strongest recommendation (Class 1, Level B-NR) for hypotension due to beta blocker poisoning 1
- Dosing protocol:
- Initial bolus: 1 U/kg regular insulin IV
- Maintenance: 0.5-1 U/kg/hour continuous infusion
- Concurrent dextrose: 0.5 g/kg bolus followed by 0.5 g/kg/hour infusion
- Titrate insulin to hemodynamic response
- Titrate dextrose to maintain glucose 100-250 mg/dL 1
- Monitor glucose frequently (every 15 minutes initially)
- Monitor potassium levels; target moderate hypokalemia (2.5-2.8 mEq/L) 1
- Benefits: Improves inotropy with fewer vasoconstrictive complications than vasopressor-only therapy 1
Vasopressors
- Strong recommendation (Class 1, Level C-LD) for hypotension 1
- Often used as initial therapy due to immediate availability and rapid action
- May be used concurrently with high-dose insulin
Second-Line Therapies
Glucagon
- Reasonable to use (Class 2a, Level C-LD) for bradycardia or hypotension 1
- Mechanism: Activates adenylate cyclase through a beta-receptor independent pathway 2
- Dosing:
- Bolus: 3-10 mg IV (0.05-0.15 mg/kg) administered slowly over 3-5 minutes
- Maintenance: 3-5 mg/hour (0.05-0.10 mg/kg/hour) infusion 1
- Titrate to hemodynamic response
- Important considerations:
Third-Line Therapies
Calcium
- May be reasonable (Class 2b, Level C-LD) for refractory shock 1
- Dosing:
- Initial: 0.3 mEq/kg (0.6 mL/kg of 10% calcium gluconate or 0.2 mL/kg of 10% calcium chloride) IV over 5-10 minutes
- Maintenance: 0.3 mEq/kg/hour infusion 1
- Titrate to hemodynamic response
- Monitor ionized calcium levels (avoid levels >2× upper limit of normal)
- Requires central venous access for sustained infusion
Electrical Pacing
- May be reasonable (Class 2b, Level C-LD) for beta blocker-induced bradycardia 1
Hemodialysis
- May be reasonable (Class 2b, Level C-LD) specifically for atenolol or sotalol poisoning 1
Refractory Cases
VA-ECMO (Veno-Arterial Extracorporeal Membrane Oxygenation)
- Reasonable to use (Class 2a, Level C-LD) for life-threatening beta blocker poisoning with cardiogenic shock refractory to pharmacological interventions 1
- Consider early if patient shows signs of deterioration despite maximal medical therapy
Therapies Not Recommended
Intravenous Lipid Emulsion
- Not likely to be beneficial (Class 3: No Benefit, Level C-LD) for life-threatening beta blocker poisoning 1
Clinical Pearls and Pitfalls
Early recognition is critical: Beta blocker overdose presents with bradycardia, hypotension, and cardiogenic shock 1, 2
Monitoring considerations:
- Frequent glucose monitoring is essential during insulin therapy
- Moderate hypokalemia is expected and should not prompt aggressive repletion 1
- Central venous access is needed for sustained calcium or concentrated dextrose infusions
Treatment escalation:
- Begin with vasopressors for immediate effect
- Rapidly initiate high-dose insulin therapy
- Add glucagon if response is inadequate
- Consider calcium for refractory cases
- Early consideration of VA-ECMO for deteriorating patients
Special considerations:
- Glucagon may interact with beta-blockers, causing transient increases in pulse and blood pressure 4
- Ensure adequate glucagon supply before initiating therapy
- Protect airway before glucagon administration in patients with CNS depression
By following this algorithmic approach to beta blocker overdose management, clinicians can optimize patient outcomes in these potentially fatal poisonings.